Compare Inovio Pharmaceuticals Inc (INO) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Omnicom Group Inc. — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Omnicom Group Inc. trades at $79.22 (market cap $23.48B). The key difference: Omnicom Group Inc. is far larger — about 263× Inovio Pharmaceuticals Inc's market cap, and Omnicom Group Inc. pays a 3.88% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | OMC | |
|---|---|---|
Market Cap | $89.27M | $23.48B |
Sector | Health | Media |
52-Week High | $2.87 | $85.80 |
52-Week Low | $1.05 | $67.27 |
Enterprise Value | $60.28M | $30.70B |
Dividend Yield | — | 3.88% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
